Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Aemetis ( (AMTX) ) is now available.
On October 15, 2025, Aemetis Biogas LLC, a subsidiary of Aemetis, Inc., announced an agreement with Protair-X Technologies Inc. and Third Eye Capital Corporation to extend the redemption date of Series A Preferred Units to December 31, 2025, and adjust the redemption price to $118.8 million. If the units are not redeemed by the new date, a credit agreement will be entered with key terms including a maturity date of September 1, 2026, and a high-interest rate, impacting Aemetis’s financial obligations and stakeholder interests.
The most recent analyst rating on (AMTX) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Aemetis stock, see the AMTX Stock Forecast page.
Spark’s Take on AMTX Stock
According to Spark, TipRanks’ AI Analyst, AMTX is a Neutral.
Aemetis’s overall stock score is primarily impacted by its poor financial performance, characterized by declining revenues and high leverage. While technical indicators suggest some positive momentum, the company’s valuation remains weak due to unprofitability. The earnings call provided a mixed outlook, with strategic expansions offset by financial challenges.
To see Spark’s full report on AMTX stock, click here.
More about Aemetis
Aemetis, Inc. operates in the renewable energy sector, focusing on producing biogas and other sustainable energy solutions.
Average Trading Volume: 965,588
Technical Sentiment Signal: Buy
Current Market Cap: $187.8M
See more data about AMTX stock on TipRanks’ Stock Analysis page.